pharmaphorum
JUNE 1, 2021
Novo Nordisk is paying $55 million upfront to secure rights to a cell therapy for heart failure developed by Japanese startup Heartseed. The Danish drugmaker has acquired exclusive rights outside Japan to Heartseed’s HS-001 therapy based on heart muscle cells (cardiomyocytes) derived from human stem cells, and is due to start the phase 1/2 LAPiS trial in Japan later this year.
Outsourcing Pharma
JUNE 1, 2021
The EMPHATHY clinical trial will enroll patients with COVID-19 to test the drugâs effectiveness in preventing worsening of symptoms and hospitalization.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Pharma Times
JUNE 2, 2021
Updated study results showed an overall response rate of 98% with a longer-term follow-up at a median of 18 months
NICE
JUNE 2, 2021
The significant growth and advancement of data-driven technologies and the possibilities being unleashed by AI have the potential to revolutionise health and social care delivery. But through my role as NICE’s director of scientific advice, I’ve seen first-hand the problems innovators face when navigating the path to market. They can end up missing important steps or focusing their time and resources in the wrong areas.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
pharmaphorum
JUNE 3, 2021
The FDA has approved a digital device developed by Cognoa that can be used to diagnose autism spectrum disorder (ASD), just a few weeks after it was filed for approval. Cognoa says the artificial intelligence (AI) based device is the first to be authorised by the US regulator that can help doctors diagnose autism in primary care, and will be launched “in the coming months” At the moment, autism can be difficult to diagnose as there are no medical markers to confirm its presence.
Outsourcing Pharma
JUNE 3, 2021
COVID-19 vaccination via Vaxxasâ novel high-density microarray patch showed 'significantly enhanced' T-cell and spike-specific antibody responses compared to needle delivery, according to a pre-print preclinical study published this week.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharma Mirror
JUNE 2, 2021
Avantor, Inc. (NYSE: AVTR), a leading global provider of mission-critical products and services to customers in the life sciences and advanced technologies & applied materials industries, announced today that it has acquired RIM Bio, a leading China-based manufacturer of single-use bioprocess bags and assemblies for biopharmaceutical manufacturing applications.
pharmaphorum
JUNE 3, 2021
The UK government is talking to AstraZeneca about ordering additional doses of its COVID-19 vaccine that will target the beta variant of SARS-CoV-2 virus first identified in South Africa, according to Health Secretary Matt Hancock. The AZ/Oxford University vaccine and other shots from Pfizer/BioNTech and Moderna are known to have less efficacy against the beta variant – also known as B.1.351 – which is estimated to be around 50% more transmissible than earlier strains.
Outsourcing Pharma
JUNE 1, 2021
According to the clinical research solutions firm, disruptions due to the pandemic did not stop the industry from fueling R&D at unprecedented levels.
Pharma Times
JUNE 2, 2021
Alkermes said that it is expecting to make Lybalvi available for patients in the fourth quarter of 2021
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharma Mirror
JUNE 2, 2021
Increasing instances of substandard, falsified and counterfeit medical products continue to pose a major challenge to the global healthcare system which is already suffering from the dire impact of COVID-19. To address this issue, ASPA and Messe Frankfurt India will unite leading experts from the pharmaceutical segment for a live panel discussion on 11 June 2021.
pharmaphorum
JUNE 2, 2021
In the latest edition of What HCPs Think , CREATION.co’s Laura Marsh looks at what healthcare professionals are saying about blood clots linked to COVID-19 vaccines. The formation of blood clots is a necessary process in order for the body to repair damage caused by injury and to slow down bleeding. However, when blood clots form inappropriately, this limits blood flow through vessels and can pose a significant health risk.
Outsourcing Pharma
JUNE 3, 2021
The pharma firm plans to use the StudyTeam platform to accelerate development, ease site burdens and improve patient matching for breast cancer studies.
Pharma Times
JUNE 2, 2021
A WHO emergency use listing (EUL) is issued when a product meets international standards for safety, efficacy and manufacturing
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharma Mirror
JUNE 1, 2021
SIRIO Group’s global Nutra-Innovation Team is rapidly intensifying efforts to create new formulations in different delivery formats for mood and stress relief. The team’s focus follows a year of global lockdowns in which consumers faced significant challenges. This has led to a rise in demand for products that enhance personal health and wellness – mind and body – with formulations that boost mood and reduce stress in strong demand.
pharmaphorum
JUNE 4, 2021
AstraZeneca and Merck & Co’s Lynparza is primed for even wider use in the treatment of breast cancer after a phase 3 trial showed it could extend the time for the cancer to return when used as adjuvant therapy. Giving Lynparza (olaparib) to women with BRCA-positive, HER2-negative breast cancer straight after chemotherapy and surgery to remove the tumour reduced the risk of recurrence, secondary cancers or death by 42% compared to placebo after 2.5 years of follow-up.
Outsourcing Pharma
JUNE 2, 2021
June 2021 marks the 40th anniversary of the publication of the first reported cases of AIDS in the US. A session at BIO Digital â featuring Dr. Anthony Fauci, Director of NIAID at the US NIH â will focus on four decades of innovation as well as the critical importance of collaboration and investment moving forward.
Pharma Times
JUNE 1, 2021
Trial is being conducted as part of a £90m Department of Health and Social Care (DHSC) initiative
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Med Ed 101
JUNE 2, 2021
There are many medications that falsely raise creatinine. This can be indicative of worsening renal function, but in some situations, it may not be an issue at all. Here’s a case scenario where we look at medications that can falsely raise creatinine by interfering with secretion in the kidney. A 63-year-old female has a history […]. The post Medications That Falsely Raise Creatinine appeared first on Med Ed 101.
pharmaphorum
JUNE 4, 2021
The inaugural Prostate Cancer Drug Development Summit is the only industry-led meeting uniting large pharma, biotech and pioneering academics with the ambitious objective of accelerating the clinical development of safe and effective therapies to treat prostate cancer. With sessions on both early and advanced stages of prostate cancer (Non-Metastatic Castrate-Resistant Prostate Cancer (nmCRPC) and Metastatic Castrate-Resistant Prostate Cancer (mCRPC) , this is a conversation not to mi
Outsourcing Pharma
JUNE 2, 2021
The online pharma event will address the COVID-19 pandemicâs impact on the industry (and vice versa) and innovation in the face of formidable challenges.
Pharma Times
JUNE 4, 2021
Officials warned that early evidence suggests there may be an increased risk of hospitalisation for Delta compared to the Alpha (Kent) strain
Med Ed 101
MAY 30, 2021
I was asked about the clinical of thiazides and hyperglycemia. To be honest, studies aren’t that great surrounding this question, and the main ones I’m aware of and could find were very old. Here’s a quick breakdown of a couple of studies on the risk of thiazides contributing to hyperglycemia. The original study that was […].
pharmaphorum
JUNE 4, 2021
Researchers in the UK have found that there was a four million rise in prescriptions for antidepressants in England during 2020, adding £139 million to NHS costs. The team from the University of Huddersfield said the findings highlight an “urgent need” for new mental health strategies to make sure antidepressants are being used appropriately, particularly in adolescents and younger adults.
Outsourcing Pharma
JUNE 4, 2021
The Digital Health Measurement Collaborative Community is bringing together stakeholders to improve approaches and technologies in research and healthcare.
Pharma Times
JUNE 3, 2021
IL-23 inhibitor helped patients achieve complete skin clearance and joint symptom improvement
pharmaphorum
JUNE 3, 2021
The National Institute for Health and Care Excellence (NICE) is world-renowned for their work assessing the clinical and cost-effectiveness of new treatments. In recognition of how the world has changed over its history, NICE is coming to the end of a period of review and consultation on their processes and methods. Leela Barham takes stock. This article appears in our digital magazine Deep Dive: Market Access 2021.
pharmaphorum
JUNE 4, 2021
Novartis’ big investment in radiopharmaceuticals for cancer seems to have paid off, after lead candidate 177Lu-PSMA-617 helped men with advanced prostate cancer and few treatment options live longer in a phase 3 trial. New data from the VISION study showed that 177Lu-PSMA-617 on top of standard care reduced the risk of death by 38% compared to standard care alone in men with PSMA-positive metastatic castration-resistant prostate cancer (CRPC) who had progressed after three or more anti-and
pharmaphorum
JUNE 3, 2021
The combination of big data and artificial intelligence/machine learning is a powerful one and nowhere more so than in healthcare. As part of BIO-Europe Spring Digital , pharmaphorum founder Dr. Paul Tunnah moderated a panel discussion about big data, AI and applications in the real world. The expert panel explored the evolving applications of big data and AI within the industry, looking beyond drug discovery to new ways these technological approaches can transform healthcare delivery.
pharmaphorum
JUNE 4, 2021
Bayer has agreed to buy Noria Therapeutics and its subsidiary PSMA Therapeutics, adding to its pipeline of radionuclide drugs for cancer as sales of its lead product in the category – Xofigo – continue to decline. . Just over three years ago, Bayer was forced to concede that its blockbuster expectations for Xofigo (radium Ra 223 dichloride) would come to nothing, after the castration-resistant prostate cancer drug was linked to more fractures and deaths when combined with Zytiga (abiraterone ace
pharmaphorum
JUNE 1, 2021
Prospects for Novartis’ ophthalmology drug Beovu have taken another dive after the drugmaker reported toxicity issues in a new phase 3 trial in wet age-related macular degeneration (AMD). On the plus side, Beovu (brolucizumab) met its efficacy objectives in the MERLIN study, but that was offset by higher rates of inflammatory reactions in the eyes – some of which could be sight threatening – compared to rival anti-VEGF therapy Eylea (aflibercept) from Bayer and Regeneron.
pharmaphorum
JUNE 2, 2021
Shares in German biotech MorphoSys have gone on the slide after it announced a $1.7 billion deal to buy its US rival Constellation Pharma and its pipeline of cancer and haematology therapies. MorphoSys said the $34 per share deal would accelerate growth by adding two clinical-stage drug candidates, namely BET inhibitor pelabresib (CPI-0610) in phase 3 trials for myelofibrosis and second-generation EZH2 inhibitor CPI-0209 in mid-stage testing for blood cancers and solid tumours.
pharmaphorum
MAY 31, 2021
Digital health player Babylon Health is exploring a merger with a so-called ‘blank cheque’ company as a route to a public listing, according to a Swedish investment group. Kinnevik AB – which holds a 16% stake in Babylon – said that a transaction with a special-purpose acquisition company (SPAC) is being explored and may or may not take place, adding that it would not comment further on the matter for the time being.
Expert insights. Personalized for you.
138 
Let's personalize your content